The 19 analysts offering 12-month price forecasts for Novartis AG have a median target of 102.01, with a high estimate of 114.64 and a low estimate of 77.96. The median estimate represents a +18.77% increase from the last price of 85.89.
The current consensus among 23 polled investment analysts is to Buy stock in Novartis AG. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.39
Reporting Date Jul 21
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.